Viasus D, Carratalà J. Legionellosis and Legionnaires’ disease. In: Oxford textbook of medicine. 6th ed. Oxford: Oxford University Press; 2020.
Google Scholar
Cunha BA, Burillo A, Bouza E. Legionnaires’ disease. Lancet. 2016;387:376–85.
PubMed
Article
Google Scholar
Fields BS, Benson RF, Besser RE. Legionella and Legionnaires’ disease: 25 years of investigation. Clin Microbiol Rev. 2002;15:506–26.
PubMed
PubMed Central
Article
Google Scholar
Priest PC, Slow S, Chambers ST, et al. The burden of Legionnaires’ disease in New Zealand (LegiNZ): a national surveillance study. Lancet Infect Dis. 2019;19:770–7.
PubMed
Article
Google Scholar
Chambers ST, Slow S, Scott-Thomas A, Murdoch DR. Legionellosis caused by non-Legionella pneumophila species, with a focus on Legionella longbeachae. Microorganisms. 2021;9:291.
PubMed
PubMed Central
Article
Google Scholar
Chauhan D, Shames SR. Pathogenicity and virulence of Legionella: intracellular replication and host response. Virulence. 2021;12(1):1122–44.
CAS
PubMed
PubMed Central
Article
Google Scholar
Burillo A, Pedro-Botet ML, Bouza E. Microbiology and epidemiology of Legionnaires’ disease. Infect Dis Clin N Am. 2017;31:7–27.
Article
Google Scholar
Viasus D, Di Yacovo S, Garcia-Vidal C, et al. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore). 2013;92:51–60.
Article
Google Scholar
Allgaier J, Lagu T, Haessler S, et al. Risk factors, management, and outcomes of Legionella pneumonia in a large, Nationally representative sample. Chest. 2021;159:1782–92.
PubMed
Article
Google Scholar
Gramegna A, Sotgiu G, Di Pasquale M, GLIMP Study Group, et al. Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective. BMC Infect Dis. 2018;18:677.
CAS
PubMed
PubMed Central
Article
Google Scholar
Arancibia F, Cortes CP, Valdés M, et al. Importance of Legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago, Chile. Chest. 2014;145:290–6.
PubMed
Article
Google Scholar
Bellew S, Grijalva CG, Williams DJ, et al. Pneumococcal and Legionella urinary antigen tests in community-acquired pneumonia: prospective evaluation of indications for testing. Clin Infect Dis. 2019;68:2026–33.
CAS
PubMed
Article
Google Scholar
Farnham A, Alleyne L, Cimini D, Balter S. Legionnaires; disease incidence and risk factors, New York, New York, USA, 2002–2011. Emerg Infect Dis. 2014;20(11):1795–802.
CAS
PubMed
PubMed Central
Article
Google Scholar
Andrea L, Dicpinigaitis PV, Fazzari MJ, Kapoor S. Legionella pneumonia in the ICU: a tertiary care center experience over 10 years. Crit Care Explor. 2021;3(8): e0508.
PubMed
PubMed Central
Article
Google Scholar
Regueiro-Mira MV, Pita-Fernández S, Pértega-Díaz S, López-Calviño B, Seoane-Pillado T, Fernández-Albalat-Ruiz M. Prognostic factors in adult patients hospitalized for pneumonia caused by Legionella pneumophila. Rev Chilena Infectol. 2015;32(4):435–44.
PubMed
Article
Google Scholar
Wingfield T, Rowell S, Peel A, Puli D, Guleri A, Sharma R. Legionella pneumonia cases over a five-year period: a descriptive, retrospective study of outcomes in a UK district hospital. Clin Med (Lond). 2013;13(2):152–9.
Article
Google Scholar
Gershengorn HB, Keene A, Dzierba AL, Wunsch H. The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia. Clin Infect Dis. 2015;60(11):e66-79.
CAS
PubMed
Article
Google Scholar
Hung TL, Li MC, Wang LR, Liu CC, Li CW, Chen PL, Syue LS, Lee NY, Ko WC. Legionnaires’ disease at a medical center in southern Taiwan. J Microbiol Immunol Infect. 2018;51(3):352–8.
PubMed
Article
Google Scholar
Dagan A, Epstein D, Mahagneh A, Nashashibi J, Geffen Y, Neuberger A, Miller A. Community-acquired versus nosocomial Legionella pneumonia: factors associated with Legionella-related mortality. Eur J Clin Microbiol Infect Dis. 2021;40(7):1419–26.
PubMed
Article
Google Scholar
Sivagnanam S, Podczervinski S, Butler-Wu SM, Hawkins V, Stednick Z, Helbert LA, Glover WA, Whimbey E, Duchin J, Cheng GS, Pergam SA. Legionnaires' disease in transplant recipients: a 15-year retrospective study in a tertiary referral center. Transpl Infect Dis. 2017;19(5)
Cooley LA, Pondo T, Francois Watkins LK, Shah P, Schrag S, Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Population-based assessment of clinical risk factors for Legionnaires’ disease. Clin Infect Dis. 2020;70:2428–31.
PubMed
Article
Google Scholar
Mudali G, Kilgore PE, Salim A, McElmurry SP, Zervos M. Trends in Legionnaires’ disease-associated hospitalizations, United States, 2006–2010. Open Forum Infect Dis. 2020;7:ofaa296.
PubMed
PubMed Central
Article
Google Scholar
Cassell K, Gacek P, Rabatsky-Ehr T, Petit S, Cartter M, Weinberger DM. Estimating the true burden of Legionnaires’ disease. Am J Epidemiol. 2019;188(9):1686–94.
PubMed
Article
Google Scholar
Walker JT. The influence of climate change on waterborne disease and Legionella: a review. Perspect Public Health. 2018;138:282–6.
CAS
PubMed
Article
Google Scholar
Neil K, Berkelman R. Increasing incidence of Legionellosis in the United States, 1990–2005: changing epidemiologic trends. Clin Infect Dis. 2008;47:591–9.
PubMed
Article
Google Scholar
Centers for Disease Control and Prevention. Legionnaires Disease Surveillance Summary Report, United States, 2016–2017. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC. https://www.cdc.gov/legionella/health-depts/surv-reporting/2016-17-surv-report-508.pdf. Accessed 1 Feb 2022.
ECDC. Legionnaires’ disease annual epidemiological report for 2019. https://www.ecdc.europa.eu/en/publications-data/legionnaires-disease-annual-epidemiological-report-2019. Accessed 1 Feb 2022.
Leung YH, Lam CK, Cheung YY, Chan CW, Chuang SK. Epidemiology of Legionnaires’ disease, Hong Kong, China, 2005–2015. Emerg Infect Dis. 2020;26:1695–702.
PubMed
PubMed Central
Article
Google Scholar
Fastl C, Devleesschauwer B, van Cauteren D, et al. The burden of Legionnaires’ disease in Belgium, 2013 to 2017. Arch Public Health. 2020;78:92.
PubMed
PubMed Central
Article
Google Scholar
Collier SA, Deng L, Adam EA, et al. Estimate of burden and direct healthcare cost of infectious waterborne disease in the United States. Emerg Infect Dis. 2021;27:140–9.
PubMed
PubMed Central
Article
Google Scholar
Baker-Goering M, Roy K, Edens C, Collier S. Economic burden of Legionnaires’ disease, United States, 2014. Emerg Infect Dis. 2021;27:255–7.
PubMed
PubMed Central
Article
Google Scholar
ECDC. European Centre for Disease Prevention and Control. Annual Epidemiological report for 2019. Legionnaires’ disease. https://www.ecdc.europa.eu/sites/default/files/documents/AER-legionnaires-2019.pdf2021. Accessed 1 Feb 2022.
Kenagy E, Priest PC, Cameron CM, et al. Risk factors for Legionella longbeachae Legionnaires’ disease. N Z Emerg Infect Dis. 2017;23(7):1148–54.
Google Scholar
World Health Organization. Legionella and the prevention of Legionellosis. WHO; 2007.
Google Scholar
Pierre DM, Baron J, Yu VL, Stout JE. Diagnostic testing for Legionnaires’ disease. Ann Clin Microbiol Antimicrob. 2017;16(1):59.
PubMed
PubMed Central
Article
CAS
Google Scholar
Essig A, von Baum H, Gonser T, Haerter G, Luck C. Microbiological diagnosis and molecular typing of Legionella strains during an outbreak of legionellosis in Southern Germany. Int J Med Microbiol. 2016;306(2):109–14.
PubMed
Article
Google Scholar
Mercante JW, Winchell JM. Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev. 2015;28(1):95–133.
CAS
PubMed
PubMed Central
Article
Google Scholar
Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, Macfarlane JT, Read RC, Roberts HJ, Levy ML, Wani M, Woodhead MA, Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1-55.
PubMed
Article
Google Scholar
Birtles RJ, Harrison TG, Samuel D, Taylor AG. Evaluation of urinary antigen ELISA for diagnosing Legionella pneumophila serogroup 1 infection. J Clin Pathol. 1990;43(8):685–90.
CAS
PubMed
PubMed Central
Article
Google Scholar
Williams A, Lever MS. Characterisation of Legionella pneumophila antigen in urine of guinea pigs and humans with Legionnaires’ disease. J Infect. 1995;30(1):13–6.
CAS
PubMed
Article
Google Scholar
Kawasaki T, Nakagawa N, Murata M, et al. Diagnostic accuracy of urinary antigen tests for legionellosis: a systematic review and meta-analysis. Respir Investig. 2021;60(2):205–14.
PubMed
Article
Google Scholar
Menéndez R, Torres A, Aspa J, Capelastegui A, Prat C, de Castro FR, Sociedad Española de Neumología y Cirugía Torácica. Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2010;46(10):543–58.
PubMed
Article
Google Scholar
Losier A, Dela Cruz CS. New testing guidelines for community-acquired pneumonia. Curr Opin Infect Dis. 2022;35(2):128–32.
CAS
PubMed
Article
Google Scholar
Rota MC, Fontana S, Montano-Remacha C, et al. Legionnaires’ disease pseudoepidemic due to falsely positive urine antigen test results. J Clin Microbiol. 2014;52(6):2279–80.
PubMed
PubMed Central
Article
Google Scholar
Como J, Moffa MA, Bhanot N, et al. Potential false-positive urine Legionella enzyme immunoassay test results. Eur J Clin Microbiol Infect Dis. 2019;38(7):1377–82.
CAS
PubMed
Article
Google Scholar
Doskeland SO, Berdal BP. Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions. J Clin Microbiol. 1980;11(4):380–4.
CAS
PubMed
PubMed Central
Article
Google Scholar
White A, Kohler RB, Wheat LJ, et al. Rapid diagnosis of Legionnaires’ disease. Trans Am Clin Climatol Assoc. 1982;93:50–62.
CAS
PubMed
PubMed Central
Google Scholar
Beraud L, Gervasoni K, Freydiere AM, et al. Comparison of Sofia Legionella FIA and BinaxNOW(R) Legionella urinary antigen card in two national reference centers. Eur J Clin Microbiol Infect Dis. 2015;34(9):1803–7.
CAS
PubMed
PubMed Central
Article
Google Scholar
Pontoizeau C, Dangers L, Jarlier V, et al. Ruling out false-positive urinary Legionella pneumophila serogroup 1 and Streptococcus pneumoniae antigen test results by heating urine. J Clin Microbiol. 2014;52(12):4347–9.
CAS
PubMed
PubMed Central
Article
Google Scholar
Higa F, Fujita J, Koide M, Haranaga S, Tateyama M. Clinical features of two cases of Legionnaires’ disease with persistence of Legionella urinary antigen excretion. Intern Med. 2008;47(3):173–8.
PubMed
Article
Google Scholar
Sopena N, Sabria M, Pedro-Botet ML, Reynaga E, Garcia-Nunez M, Dominguez J, et al. Factors related to persistence of Legionella urinary antigen excretion in patients with Legionnaires’ disease. Eur J Clin Microbiol Infect Dis. 2002;21(12):845–8.
CAS
PubMed
Article
Google Scholar
Helbig JH, Uldum SA, Bernander S, et al. Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires’ disease. J Clin Microbiol. 2003;41(2):838–40.
PubMed
PubMed Central
Article
Google Scholar
Viasus D, Calatayud L, McBrown MV, Ardanuy C, Carratala J. Urinary antigen testing in community-acquired pneumonia in adults: an update. Expert Rev Anti Infect Ther. 2019;17(2):107–15.
CAS
PubMed
Article
Google Scholar
Muyldermans A, Descheemaeker P, Boel A, et al. What is the risk of missing legionellosis relying on urinary antigen testing solely? A retrospective Belgian multicenter study. Eur J Clin Microbiol Infect Dis. 2020;39(4):729–34.
CAS
PubMed
Article
Google Scholar
Vaccaro L, Izquierdo F, Magnet A, et al. First case of Legionnaires’ disease caused by Legionella anisa in Spain and the limitations on the diagnosis of Legionella non-pneumophila infections. PLoS ONE. 2016;11(7): e0159726.
PubMed
PubMed Central
Article
CAS
Google Scholar
Okada C, Kura F, Wada A, Inagawa H, Lee GH, Matsushita H. Cross-reactivity and sensitivity of two Legionella urinary antigen kits, Biotest EIA and Binax NOW, to extracted antigens from various serogroups of L. pneumophila and other Legionella species. Microbiol Immunol. 2002;46(1):51–4.
CAS
PubMed
Article
Google Scholar
Ito A, Yamamoto Y, Ishii Y, Okazaki A, Ishiura Y, Kawagishi Y, et al. Evaluation of a novel urinary antigen test kit for diagnosing Legionella pneumonia. Int J Infect Dis. 2020;103:42–7.
PubMed
Article
CAS
Google Scholar
Nakamura A, Fukuda S, Kusuki M, Watari H, Shimura S, Kimura K, et al. Evaluation of five Legionella urinary antigen detection kits including new Ribotest Legionella for simultaneous detection of ribosomal protein L7/L12. J Infect Chemother. 2021;27(10):1533–5.
CAS
PubMed
Article
Google Scholar
Robert S, Lhommet C, Brun CL, et al. Diagnostic performance of multiplex PCR on pulmonary samples versus nasopharyngeal aspirates in community-acquired severe lower respiratory tract infections. J Clin Virol. 2018;108:1–5.
CAS
PubMed
PubMed Central
Article
Google Scholar
Diederen BM, de Jong CM, Kluytmans JA, van der Zee A, Peeters MF. Detection and quantification of Legionella pneumophila DNA in serum: case reports and review of the literature. J Med Microbiol. 2006;55(Pt 5):639–42.
PubMed
Article
Google Scholar
Diederen BM, de Jong CM, Marmouk F, Kluytmans JA, Peeters MF, Van der Zee A. Evaluation of real-time PCR for the early detection of Legionella pneumophila DNA in serum samples. J Med Microbiol. 2007;56(Pt 1):94–101.
CAS
PubMed
Article
Google Scholar
Matsiota-Bernard P, Waser S, Vrioni G. Detection of Legionella pneumophila DNA in urine and serum samples from patients with pneumonia. Clin Microbiol Infect. 2000;6(4):223–5.
CAS
PubMed
Article
Google Scholar
Murdoch DR, Walford EJ, Jennings LC, et al. Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia. Clin Infect Dis. 1996;23(3):475–80.
CAS
PubMed
Article
Google Scholar
Mentasti M, Kese D, Echahidi F, et al. Design and validation of a qPCR assay for accurate detection and initial serogrouping of Legionella pneumophila in clinical specimens by the ESCMID Study Group for Legionella Infections (ESGLI). Eur J Clin Microbiol Infect Dis. 2015;34(7):1387–93.
CAS
PubMed
Article
Google Scholar
Benitez AJ, Winchell JM. Clinical application of a multiplex real-time PCR assay for simultaneous detection of Legionella species, Legionella pneumophila, and Legionella pneumophila serogroup 1. J Clin Microbiol. 2013;51(1):348–51.
CAS
PubMed
PubMed Central
Article
Google Scholar
Merault N, Rusniok C, Jarraud S, et al. Specific real-time PCR for simultaneous detection and identification of Legionella pneumophila serogroup 1 in water and clinical samples. Appl Environ Microbiol. 2011;77(5):1708–17.
CAS
PubMed
Article
Google Scholar
Ginevra C, Chastang J, David S, et al. A real-time PCR for specific detection of the Legionella pneumophila serogroup 1 ST1 complex. Clin Microbiol Infect. 2020;26(4):514 e1-e6.
Article
CAS
Google Scholar
Mentasti M, Cassier P, David S, et al. Rapid detection and evolutionary analysis of Legionella pneumophila serogroup 1 sequence type 47. Clin Microbiol Infect. 2017;23(4):264 e1-e9.
Article
CAS
Google Scholar
Avni T, Bieber A, Green H, Steinmetz T, Leibovici L, Paul M. Diagnostic accuracy of PCR alone and compared to urinary antigen testing for detection of Legionella spp.: a systematic review. J Clin Microbiol. 2016;54(2):401–11.
CAS
PubMed
PubMed Central
Article
Google Scholar
Ricci ML, Grottola A, Fregni Serpini G, et al. Improvement of Legionnaires' disease diagnosis using real-time PCR assay: a retrospective analysis, Italy, 2010 to 2015. Euro Surveill. 2018;23(50):1800032.
PubMed Central
Article
Google Scholar
Rothe K, Spinner CD, Panning M, et al. Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ). Infection. 2021;49(6):1299–306.
CAS
PubMed
PubMed Central
Article
Google Scholar
Huang Y, Ma Y, Miao Q, et al. Arthritis caused by Legionella micdadei and Staphylococcus aureus: metagenomic next-generation sequencing provides a rapid and accurate access to diagnosis and surveillance. Ann Transl Med. 2019;7(20):589.
CAS
PubMed
PubMed Central
Article
Google Scholar
Wang Y, Dai Y, et al. Case report: metagenomic next-generation sequencing in diagnosis of Legionella pneumophila pneumonia in a patient after umbilical cord blood stem cell transplantation. Front Med (Lausanne). 2021;8: 643473.
PubMed
PubMed Central
Article
Google Scholar
Yue R, Wu X, Li T, Chang L, Huang X, Pan L. Early detection of Legionella pneumophila and Aspergillus by mNGS in a critically ill patient with Legionella Pneumonia after extracorporeal membrane oxygenation treatment: case report and literature review. Front Med (Lausanne). 2021;8: 686512.
PubMed
PubMed Central
Article
Google Scholar
Heath CH, Grove DI, Looke DF. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis. 1996;15:286–90.
CAS
PubMed
Article
Google Scholar
Gacouin A, Le Tulzo Y, Lavoue S, et al. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy. Intensive Care Med. 2002;28:686–91.
CAS
PubMed
Article
Google Scholar
Falcone M, Russo A, Tiseo G, Cesaretti M, Guarracino F, Menichetti F. Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy. Infection. 2021;49:321–5.
CAS
PubMed
Article
Google Scholar
Chidiac C, Che D, Pires-Cronenberger S, French Legionnaires’ Disease Study Group, et al. Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J. 2012;39:963–70.
CAS
PubMed
Article
Google Scholar
Woodhead M, Blasi F, Ewig S, Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases, et al. Guidelines for the management of adult lower respiratory tract infections—full version. Clin Microbiol Infect. 2011;17(Suppl 6):E1-59.
PubMed
PubMed Central
Article
Google Scholar
Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45–67.
PubMed
PubMed Central
Article
Google Scholar
Jasper AS, Musuuza JS, Tischendorf JS, et al. Are fluoroquinolones or macrolides better for treating Legionella Pneumonia? A systematic review and meta-analysis. Clin Infect Dis. 2021;72:1979–89.
CAS
PubMed
Article
Google Scholar
Kato H, Hagihara M, Asai N, et al. Meta-analysis of fluoroquinolones versus macrolides for treatment of Legionella pneumonia. J Infect Chemother. 2021;27:424–33.
CAS
PubMed
Article
Google Scholar
Torres A, Cillóniz C. Are macrolides as effective as fluoroquinolones in Legionella Pneumonia? Yes, but. Clin Infect Dis. 2021;72:1990–1.
CAS
PubMed
Article
Google Scholar
Cocuzza CE, Martinelli M, Perdoni F, Giubbi C, Vinetti MEA, Calaresu E, Frugoni S, Scaturro M, Ricci ML, Musumeci R. Antibiotic susceptibility of environmental Legionella pneumophila strains isolated in Northern Italy. Int J Environ Res Public Health. 2021;18(17):9352.
CAS
PubMed
PubMed Central
Article
Google Scholar
Edelstein PH. Azithromycin phenotypic versus clinical resistance. Antimicrob Agents Chemother. 2019;64(1):e01986-e2019.
PubMed
PubMed Central
Article
Google Scholar
Natås OB, Brekken AL, Bernhoff E, Hetland MAK, Löhr IH, Lindemann PC. Susceptibility of Legionella pneumophila to antimicrobial agents and the presence of the efflux pump LpeAB. J Antimicrob Chemother. 2019;74(6):1545–50.
PubMed
Article
CAS
Google Scholar
Martin SJ, Pendland SL, Chen C, Schreckenberger P, Danziger LH. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella. Antimicrob Agents Chemother. 1996;40:1419–21.
CAS
PubMed
PubMed Central
Article
Google Scholar
Baltch AL, Smith RP, Ritz W. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila. Antimicrob Agents Chemother. 1995;39:1661–6.
CAS
PubMed
PubMed Central
Article
Google Scholar
Descours G, Ginevra C, Ader F, et al. Rifampicin-macrolide synergy against Legionella pneumophila serogroup 1 in human macrophages using a quantitative real-time PCR assay. Int J Antimicrob Agents. 2011;38:188–9.
CAS
PubMed
Article
Google Scholar
Martin SJ, Pendland SL, Chen C, Schreckenberger PC, Danziger LH. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin. Diagn Microbiol Infect Dis. 1997;29:167–71.
CAS
PubMed
Article
Google Scholar
Varner TR, Bookstaver PB, Rudisill CN, Albrecht H. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia. Ann Pharmacother. 2011;45:967–76.
CAS
PubMed
Article
Google Scholar
Grau S, Antonio JM, Ribes E, Salvadó M, Garcés JM, Garau J. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia. Int J Antimicrob Agents. 2006;28:249–52.
CAS
PubMed
Article
Google Scholar
Blázquez-Garrido RM, Espinosa-Parra FJ, Alemany-Francés L, et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin Infect Dis. 2005;40:800–6.
PubMed
Article
Google Scholar
Pedro-Botet ML, García-Cruz A, Tural C, et al. Severe Legionnaires’ disease successfully treated with levofloxacin and azithromycin. J Chemother. 2006;18:559–61.
CAS
PubMed
Article
Google Scholar
Trübel HK, Meyer HG, Jahn B, Knuf M, Kamin W, Huth RG. Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child. Scand J Infect Dis. 2002;34:219–21.
PubMed
Article
Google Scholar
Nakamura S, Yanagihara K, Izumikawa K, et al. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila. J Infect. 2009;59:222–4.
PubMed
Article
Google Scholar
Lan SH, Lai CC, Chang SP, Lu LC, Hung SH, Lin WT. Five-day antibiotic treatment for community-acquired bacterial pneumonia: a systematic review and meta-analysis of randomized controlled trials. J Global Antimicrob Resist. 2020;23:94–9.
Article
Google Scholar
Tansarli GS, Mylonakis E. Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults. Antimicrob Agents Chemother. 2018;62:e00635-e718.
CAS
PubMed
PubMed Central
Article
Google Scholar
Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, Grammatikos AP, Athanassa Z, Falagas ME. Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs. 2008;68:1841–54.
CAS
PubMed
Article
Google Scholar
el Moussaoui R, de Borgie CA, van den Broek P, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ. 2006;332:1355.
PubMed
PubMed Central
Article
Google Scholar
Siegel RE, Alicea M, Lee A, Blaiklock R. Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study. Am J Ther. 1999;6:217–22.
CAS
PubMed
Article
Google Scholar
Uranga A, España PP, Bilbao A, et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med. 2016;176:1257–65.
PubMed
Article
Google Scholar
Kuzman I, Soldo I, Schönwald S, Culig J. Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. Scand J Infect Dis. 1995;27:503–5.
CAS
PubMed
Article
Google Scholar
Amsden GW. Treatment of Legionnaires’ disease. Drugs. 2005;65:605–14.
CAS
PubMed
Article
Google Scholar
Chahin A, Opal SM. Severe pneumonia caused by Legionella pneumophila: differential diagnosis and therapeutic considerations. Infect Dis Clin N Am. 2017;31:111–21.
Article
Google Scholar
Lanternier F, Ader F, Pilmis B, Catherinot E, Jarraud S, Lortholary O. Legionnaires’ disease in compromised hosts. Infect Dis Clin N Am. 2017;31:123–35.
Article
Google Scholar
Agence française de sécurité sanitaire des produits de santé. Traitement antibiotique de la légionellose chez l’adulte. https://www.infectiologie.com/UserFiles/File/medias/_documents/consensus/2011-afssaps-MAP-legionellose.pdf. Accessed 1 Feb 2022.